Billionaire Elon Musk’s brain chip company Neuralink is officially recruiting human beings for a clinical trial, the biotech firm announced on Tuesday.
The trial will be open to individuals with quadriplegia resulting from cervical spinal cord injury or amyotrophic lateral sclerosis (ALS), Neuralink announced on its website. It seeks to assess the brain implant’s safety, the performance of its “surgical robot” and gauge the chip’s effectiveness in allowing paralyzed people to influence external devices through their thoughts.
Read More